Indirect Comparison Topotecan Cervical Carcinoma

Status Completed

Clinical Trial Summary

Indirect comparisons were performed using data from GOG-0179 versus GOG-0169 to permit comparison of topotecan in combination with cisplatin versus cisplatin plus paclitaxel via the common comparator of cisplatin monotherapy. Both GOG-0179 and GOG-0169 were conducted in patients with stage IVB, recurrent or persistent carcinoma of the cervix, but there were some differences between the respective study populations. Patients with prior chemotherapy were eligible for GOG-0179 but ineligible for GOG-0169 (except when chemotherapy was used for radiation sensitisation). Fewer patients had received chemotherapy as a radiosensitiser in GOG-0169 (27%) than in GOG-0179 (~60%) and these patients were unevenly distributed between treatment arms in GOG-0169. In addition, the proportion of patients receiving cisplatin as a radiosensitiser in GOG-0169 is unknown. For these reasons, there are limitations associated with the indirect meta-analysis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01345279
Study type	Observational
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	N/A
Start date	June 2009
Completion date	July 2009

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04537156` - Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)	Phase 3
Completed	`NCT02907333` - Testing Use of Condoms on Regression of Cervical Intraepithelial Neoplasia	N/A
Recruiting	`NCT02576262` - HPV Integration Testing for Human Papillomavirus-Positive Women	N/A
Completed	`NCT01029990` - Randomized Controlled Trial to Study Interventions to Increase Participation in Cervical Cancer Screening Program	Phase 0
Recruiting	`NCT05078528` - Low-cost Imaging Technology for Global Prevention of Cervical Cancer	N/A
Recruiting	`NCT05502367` - A Study of ABI-2280 Vaginal Tablet in Participants With Cervical Intraepithelial Neoplasia	Phase 1/Phase 2
Completed	`NCT02494310` - HRME: Screening for Cervical Cancer and Its Precursors in Low‐Resource Settings	N/A
Active, not recruiting	`NCT03429582` - Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device	N/A
Active, not recruiting	`NCT02140021` - Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer	N/A
Not yet recruiting	`NCT05510830` - Diagnostic Cervical Conization for Persistent Infection or Integration of HPV	N/A
Completed	`NCT02237326` - Visual Inspection With Acetic Acid Compared to Lugol's Iodine in HIV-infected Women	N/A
Completed	`NCT00316706` - Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine	Phase 3
Withdrawn	`NCT03143491` - Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)	Phase 2
Completed	`NCT03293628` - Comparing Two Techniques of Haemostasis After Cervical Conization	Phase 2
Recruiting	`NCT05266898` - Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV	Phase 4
Completed	`NCT02481414` - A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions	Phase 2
Completed	`NCT02247999` - Improving Cervical Cancer Screening Among HIV-Infected Women in India
Recruiting	`NCT04650711` - Immunohistochemical Staining of p16 for the Screening of Cervical Cancer	Phase 2
Recruiting	`NCT04646954` - DNA Methylation Testing for the Screening of Uterine Cervical Lesion	Phase 3
Completed	`NCT01544478` - V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)	Phase 4